Approval

Discussion in 'NPS Pharmaceuticals' started by Anonymous, Jan 23, 2015 at 4:35 PM.

Tags: Add Tags
  1. Anonymous

    Anonymous Guest

    Did you get approval????
     

  2. Anonymous

    Anonymous Guest

    yes lifetime use ok no rems
     
  3. Anonymous

    Anonymous Guest

    Natpara is going to be a tough, tough, sell. Almost didn't get approved. Some low hanging fruit early on, but by November.........good luck........
     
  4. Anonymous

    Anonymous Guest

    Why do you say that? Where's your evidence?
     
  5. Anonymous

    Anonymous Guest

    8-5 close vote by FDA last fall, 3 month delay in approval, REMS, compliance with injections, osteosarcoma risk and cost could scare endos. But most importantly, how NPS management has been spouting the market is 60,000 new patients per year. It's not, it's a smaller subset (see below.) Talk to top endos and H&N surgeons they'll tell you 12,000-15,000. If I'm a rep, I'd worry that Natpara goals are going to be more geared towards the 60,000 population than the 15,000. In other words, unrealistic sales quotas. NPS might have exaggerated this patient population to get sold. I'm not saying there isn't a market, but be careful, it's not as big as being touted. Below is what you need to look at very closely as far as "well controlled" patients on calcium and vitamin D. That's the vast majority of hypoparathyroid patients:

    "Because of the potential risk of osteosarcoma, Natpara is recommended only for patients who cannot be well-controlled on calcium supplements and active forms of vitamin D alone. Natpara was not studied in patients with hypoparathyroidism caused by calcium-sensing receptor mutations or in patients with acute post-surgical hypoparathyroidism."
     
  6. Anonymous

    Anonymous Guest

    Funny cause none of that is evidence that it almost didn't get approved.
     
  7. Anonymous

    Anonymous Guest


    Manager here. These are all moot points. Layoffs will be announced soon for both the Natpara and Gattex salesforce.
     
  8. Anonymous

    Anonymous Guest

    I call bullshit.

    No one at NPS or anywhere else for that matter has claimed that the market is 60K new patients per year.

    Go troll somewhere else.
     
  9. Anonymous

    Anonymous Guest

    So they aren't hiring the rest of the salesforce for NATPARA?
     
  10. Anonymous

    Anonymous Guest

    With shire buying NPS I am sure all hiring is on hold. Shire is all about cost cutting right now to stay "lean and mean" to get better price to sell the company and people like the CEO can make a fortune. Wake up people its all about money and not about people.
     
  11. Anonymous

    Anonymous Guest

    Not true. Nps was told to fill all vacant sales positions.
     
  12. Anonymous

    Anonymous Guest

    Absolute BS. We are in a hiring freeze since the offer (candidate packages approved before the offer can move forward but nothing more).
     
  13. Anonymous

    Anonymous Guest

    We are filling open territories anyone who says anything different does not know what they are talking about. Prior poster is a troll looking to scare people. Focus on your job. Anything is out of our control anyway....
     
  14. Anonymous

    Anonymous Guest

    Total bullshit. The full launch team will be hired as planned. Most positions are filled, however.